Filters
reset allOther countries
Results: 1 to 14 of 14
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
LAMA1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Invitae Brain Malformations Panel Invitae United States | 247 | 161 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Fulgent Genetics United States | 505 | 132 |
|
Fulgent Genetics United States | 533 | 149 |
|
Fulgent Genetics United States | 18 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Results: 1 to 14 of 14
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.